Physician profile
Koji Ebersole
NPI 1508061425
$123,313.57
in general payments reported to CMS, 2019-2025
18 companies · $24K in 2025
The $24K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $1,823 · 2021: $29K · 2022: $34K · 2023: $581 · 2024: $4,614 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Consulting Fee: $5,098 · Food and Beverage: $3,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,426.06 |
| Consulting Fee | $5,098.20 |
| Food and Beverage | $3,457.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $55,553.66 | 2019-2022 | |
| Stryker Corporation | $51,684.22 | 2019-2025 | Surpass Evolve, Target, Evolve |
| Medical Device Business Services, INC. | $10,434.36 | 2024-2025 | Emboguard |
| Corindus INC. | $1,490.79 | 2019 | |
| Siemens Medical Solutions USA, INC. | $1,443.83 | 2024 | Artis Icono Biplane |
| Depuy Synthes Sales INC. | $792.95 | 2022-2025 | Trufill, Cerepak Uniform, Embotrap |
| Rapid Medical Ltd | $383.06 | 2023-2024 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Medtronic, INC. | $382.85 | 2021-2023 | Pipeline |
| Penumbra, INC. | $363.63 | 2020-2024 | Penumbra System |
| Irras USA, INC. | $254.03 | 2021 | |
| Route 92 Medical, INC. | $134.97 | 2022 | |
| Qapel Medical INC | $124.44 | 2025 | |
| Zimmer Biomet Holdings, INC. | $110.98 | 2019 | |
| Microtransponder, INC. | $92.63 | 2024 | |
| Cordis US Corp. | $25.58 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $23.64 | 2025 | Trinav Infusion System |
| Cardiva Medical, INC. | $17.95 | 2025 | Cardiva Vascade 6/7f Vcs |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Koji Ebersole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.